NCT03577977View on ClinicalTrials.gov

Betaferon Use in Children and Adolescents With Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

June 1, 2008

Primary Completion Date

April 15, 2009

Study Completion Date

April 15, 2009

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)

Betaferon was injected subcutaneously as prescribed by the treating physician.

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT03577977 - Betaferon Use in Children and Adolescents With Multiple Sclerosis | Biotech Hunter | Biotech Hunter